Average FDA approval times decrease

被引：0
|
作者：
不详
机构：
来源：
OPTOMETRY AND VISION SCIENCE | 2001年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [1] FDA to slash drug approval times
    不详
    CHEMISTRY & INDUSTRY, 2003, (13) : 5 - 5
  • [2] Factors Associated with Multiple FDA Review Cycles and Approval Phase Times
    Joseph A. DiMasi
    Laura Faden
    Drug information journal : DIJ / Drug Information Association, 2009, 43 (2): : 201 - 225
  • [3] Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates
    Ernst R. Berndt
    Adrian H. B. Gottschalk
    Tomas J. Philipson
    Matthew W. Strobeck
    Nature Reviews Drug Discovery, 2005, 4 : 545 - 554
  • [4] Industry funding of the FDA: Effects of PDUFA on approval times and withdrawal rates
    Berndt, ER
    Gottschalk, AHB
    Philipson, TJ
    Strobeck, MW
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (07) : 545 - 554
  • [5] Factors Associated With Multiple FDA Review Cycles and Approval Phase Times
    DiMasi, Joseph A.
    Faden, Laura
    DRUG INFORMATION JOURNAL, 2009, 43 (02): : 201 - 225
  • [6] FDA approval
    不详
    GERIATRICS, 2001, 56 (11) : 16 - 16
  • [7] FDA approval
    不详
    GERIATRICS, 2001, 56 (09) : 16 - 16
  • [8] FDA approval
    不详
    GERIATRICS, 2001, 56 (03) : 20 - 20
  • [9] Approval times for new drugs: Does the source of funding for FDA staff matter?
    Carpenter, D
    Chernew, M
    Smith, DG
    Fendrick, AM
    HEALTH AFFAIRS, 2004, 23 (01) : W618 - W624
  • [10] FDA approval for ACTIS
    不详
    MODERN PLASTICS, 2000, 77 (09): : 10 - 10
12345